Quarterly results

• 2012 Third Quarter - released 31 October 2012

  Released 31 October 2012

  Simon Dingemans, CFO, discusses our Q3 results 2012.

  • Listen to the webcast

  

  Key highlights

  • Core EPS of 26.5p
  • Dividend of 18p (+ 6%)
  • Further successful R&D delivery: phase III programmes completed for 6 novel medicines in 2012
  • Continued strong cash generation and returns to shareholders

  Related downloads

  • Q3 2012 results announcement PDF - 293.8KB
  • Q3 2012 actual growth schedules PDF - 32.2KB
  • Q3 2012 US dollar translation PDF - 31.2KB

• 2012 Second Quarter - released 25 July 2012

  Released 25 July 2012

  Watch Sir Andrew Witty, CEO, discuss our second quarter results 2012.

  • CEO Sir Andrew Witty discusses second quarter results
  • View the press release

  

  Key highlights

  • Core EPS of 26.4p
  • Dividend of 17p (up 6%)
  • Significant late-stage pipeline delivery

  Related downloads

  • Q2 2012 results announcement PDF - 301.0KB
  • Q2 2012 analyst presentation PDF - 2.2MB
  • Q2 2012 analyst presentation (printable version) PDF - 1.0MB
  • Q2 2012 actual growth schedules PDF - 37.0KB
  • Q2 2012 US dollar translation PDF - 32.8KB

• 2012 First Quarter - released 25 April 2012

  Released 25 April 2012

  Watch Simon Dingemans, CFO, discuss our first quarter results 2012.

  • Listen to the webcast
  • Watch CFO interview for Q1 2012

  

  Key highlights

  • Sales growth of +2% CER
  • Further R&D delivery, operational leverage and continued returns to shareholders
  • Core EPS 27.3p (+7%), dividend up 6% to 17p

  Related downloads

  • Q1 2012 results announcement PDF - 258.7KB
  • Q1 2012 Simon Dingemans transcript PDF - 35.5KB
  • Q1 2012 actual growth schedules PDF - 22.5KB
  • Q1 2012 US dollar translation PDF - 24.9KB

• 2011 Fourth Quarter - released 07 February 2012

  Released 07 February 2012

  Sir Andrew Witty, CEO, discusses our fourth quarter results 2011.

  • Listen to the webcast
  • Watch Andrew Witty on CNBC's "Squawk on the Street"

  

  Key highlights

  • 2011 underlying sales +4% (reported -3%)
  • EPS before major restructuring* 114.1p
  • Total dividends of 75p

  Related downloads

  • Q4 2011 results announcement PDF - 331.1KB
  • Q4 2011 Andrew Witty video transcript PDF - 104.1KB
  • Q4 2011 Simon Dingemans video transcript PDF - 27.7KB
  • Q4 2011 analyst presentation PDF - 1.8MB
  • Q4 2011 restated quarterly product analysis PDF - 96.8KB
  • Q4 2011 actual growth schedules PDF - 47.4KB
  • Q4 2011 US dollar translation PDF - 45.1KB